|
1
|
Schwartzbaum JA, Fisher JL, Aldape KD and
Wrensch M: Epidemiology and molecular pathology of glioma. Nat Clin
Pract Neurol. 2:494–503. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ohashi R, Matsuda Y, Ishiwata T and Naito
Z: Downregulation of fibroblast growth factor receptor 2 and its
isoforms correlates with a high proliferation rate and poor
prognosis in high-grade glioma. Oncol Rep. 32:1163–1169. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Buczkowicz P, Bartels U, Bouffet E, Becher
O and Hawkins C: Histopathological spectrum of paediatric diffuse
intrinsic pontine glioma: Diagnostic and therapeutic implications.
Acta Neuropathol. 128:573–581. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miller JJ and Wen PY: Emerging targeted
therapies for glioma. Expert Opin Emerg Drugs. 21:441–452. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yun DP, Wang YQ, Meng DL, Ji YY, Chen JX,
Chen HY and Lu DR: Actin-capping protein CapG is associated with
prognosis, proliferation and metastasis in human glioma. Oncol Rep.
39:1011–1022. 2018.PubMed/NCBI
|
|
6
|
Suh CH, Kim HS, Jung SC, Choi CG and Kim
SJ: Perfusion MRI as a diagnostic biomarker for differentiating
glioma from brain metastasis: A systematic review and
meta-analysis. Eur Radiol. 28:3819–3831. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Su L, Yang K, Li S, Liu C, Han J, Zhang Y
and Xu G: Enolase-phosphatase 1 as a novel potential malignant
glioma indicator promotes cell proliferation and migration. Oncol
Rep. 40:2233–2241. 2018.PubMed/NCBI
|
|
8
|
Li J, Xu L, Bao Z, Xu P, Chang H, Wu J,
Bei Y, Xia L, Wu P and Cui G: High expression of PIWIL2 promotes
tumor cell proliferation, migration and predicts a poor prognosis
in glioma. Oncol Rep. 38:183–192. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou L, Wang Y, Zhang YT, Geng YP, Si LS
and Wang YL: Proteomics-based analysis of a pair of glioma cell
lines with different tumor forming characteristics. Neurosci Lett.
401:59–64. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tan J, Liu M, Zhang JY, Yao YL, Wang YX,
Lin Y, Song K, Tan J, Wu JR, Cui YH, et al: Capillary morphogenesis
protein 2 is a novel prognostic biomarker and plays oncogenic roles
in glioma. J Pathol. 245:160–171. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hayashi T, Hayakawa Y, Koh M, Tomita T,
Nagai S, Kashiwazaki D, Sugimori M, Origasa H and Kuroda S: Impact
of a novel biomarker, T-LAK cell-originating protein kinase (TOPK)
expression on outcome in malignant glioma. Neuropathology.
38:144–153. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ribom D, Westman-Brinkmalm A, Smits A and
Davidsson P: Elevated levels of alpha-2-Heremans-Schmid
glycoprotein in CSF of patients with low-grade gliomas. Tumour
Biol. 24:94–99. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Iwadate Y, Sakaida T, Hiwasa T, Nagai Y,
Ishikur H, Takiguchi M and Yamaura A: Molecular classification and
survival prediction in human gliomas based on proteome analysis.
Cancer Res. 64:2496–2501. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Schwartz M, Meyer B, Wirnitzer B and Hopf
C: Standardized processing of MALDI imaging raw data for
enhancement of weak analyte signals in mouse models of gastric
cancer and Alzheimer's disease. Anal Bioanal Chem. 407:2255–2264.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wildburger NC, Wood PL, Gumin J, Lichti
CF, Emmett MR, Lang FF and Nilsson CL: ESI-MS/MS and MALDI–IMS
localization reveal alterations in phosphatidic acid,
diacylglycerol, and DHA in glioma stem cell xenografts. J Proteome
Res. 14:2511–2519. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Eberlin LS, Liu X, Ferreira CR, Santagata
S, Agar NY and Cooks RG: Desorption electrospray ionization then
MALDI mass spectrometry imaging of lipid and protein distributions
in single tissue sections. Anal Chem. 83:8366–8371. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shrivas K, Hayasaka T, Goto-Inoue N,
Sugiura Y, Zaima N and Setou M: Ionic matrix for enhanced MALDI
imaging mass spectrometry for identification of phospholipids in
mouse liver and cerebellum tissue sections. Anal Chem.
82:8800–8806. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wishart DS, Feunang YD, Marcu A, Guo AC,
Liang K, Vázquez-Fresno R, Sajed T, Johnson D, Li C, Karu N, et al:
HMDB 4.0: The human metabolome database for 2018. Nucleic Acids
Res. 46:D608–D617. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lian HW, Zhou Y, Jian ZH and Liu RZ:
MiR-323-5p acts as a tumor suppressor by targeting the insulin-like
growth factor 1 receptor in human glioma cells. Asian Pac J Cancer
Prev. 15:10181–10185. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lin M, Liao W, Dong M, Zhu R, Xiao J, Sun
T, Chen Z, Wu B and Jin J: Exosomal neutral sphingomyelinase 1
suppresses hepatocellular carcinoma via decreasing the ratio of
sphingomyelin/ceramide. FEBS J. 285:3835–3848. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Catapano ER, Natale P, Monroy F and
López-Montero I: The enzymatic sphingomyelin to ceramide conversion
increases the shear membrane viscosity at the air-water interface.
Adv Colloid Interface Sci. 247:555–560. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gao X, Lowry PR, Zhou X, Depry C, Wei Z,
Wong GW and Zhang J: PI3K/Akt signaling requires spatial
compartmentalization in plasma membrane microdomains. Proc Natl
Acad Sci USA. 108:14509–14514. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou Q, Zhang J, Cui Q, Li X, Gao G, Wang
Y, Xu Y and Gao X: GSK1904529A, an insulin-like growth factor-1
receptor inhibitor, inhibits glioma tumor growth, induces apoptosis
and inhibits migration. Mol Med Rep. 12:3381–3385. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Arun S, Ravisankar S and Vanisree AJ:
Implication of connexin30 on the stemness of glioma: Connexin30
reverses the malignant phenotype of glioma by modulating IGF-1R,
CD133 and cMyc. J Neurooncol. 135:473–485. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liao YX, Zhang ZP, Zhao J and Liu JP:
Effects of fibronectin 1 on cell proliferation, senescence and
apoptosis of human glioma cells through the PI3K/Akt signaling
pathway. Cell Physiol Biochem. 48:1382–1396. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nicoletti NF, Erig TC, Zanin RF, Pereira
TC, Bogo MR, Campos MM and Morrone FB: Mechanisms involved in
kinin-induced glioma cells proliferation: The role of ERK1/2 and
PI3K/Akt pathways. J Neurooncol. 120:235–244. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Scheidegger R, Wong ET and Alsop DC:
Contributors to contrast between glioma and brain tissue in
chemical exchange saturation transfer sensitive imaging at 3 Tesla.
Neuroimage. 99:256–268. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang J, Fan Y, He M, Ma X, Song Y, Liu M
and Xu J: Accuracy of Raman spectroscopy in differentiating brain
tumor from normal brain tissue. Oncotarget. 8:36824–36831.
2017.PubMed/NCBI
|
|
29
|
Krafft C, Sobottka SB, Schackert G and
Salzer R: Analysis of human brain tissue, brain tumors and tumor
cells by infrared spectroscopic mapping. Analyst. 129:921–925.
2004. View
Article : Google Scholar : PubMed/NCBI
|
